Article
Hepatocarcinogenesis Driven by GSNOR Deficiency Is Prevented by iNOS Inhibition
26 Feb 2013
Abstract excerpt
Hepatocellular carcinoma (HCC) is one of the most common and deadly human cancers and it remains poorly managed. Human HCC development is often associated both with elevated expression of inducible nitric oxide synthase (iNOS) and with genetic deletion of the major denitrosylase S-nitrosoglutathione reductase (GSNOR/ADH5). However, their causal involvement in human HCC is not established. In mice, GSNOR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
